Product Description: Nebidrazine is a centrally-acting hypotensive agent compared to clonidine, demonstrating weaker cardiovascular effects in rats. It induces dose-dependent hypotension and bradycardia when administered intracerebroventricularly (i.c.v.), with significantly lower sedative potential than clonidine in conscious rats. Yohimbine attenuates the cardiovascular effects of both Nebidrazine and clonidine, suggesting involvement of central alpha-autoreceptors sensitive to yohimbine. Unlike clonidine, Nebidrazine does not affect peripheral alpha-adrenoceptors in pithed rats, indicating a selective central mechanism. Chemical sympathectomy reduces Nebidrazine's cardiovascular effects more than clonidine's, and metiamide diminishes responses to both drugs, implicating central histamine receptors. These findings highlight Nebidrazine's distinct pharmacological profile and potential therapeutic application in managing hypertension through central alpha-autoreceptor stimulation[1].
Applications: Neuroscience-Neuromodulation
Formula: C9H8Cl2N6
References: [1]A COMPARISON OF THE CARDIOVASCULAR AND SEDATIVE ACTIONS OF THE x-ADRENOCEPTOR AGONISTS, FLA-136 AND CLONIDINE, IN THE RAT
CAS Number: 55248-23-2
Molecular Weight: 271.11
Research Area: Cardiovascular Disease
Target: Histamine Receptor
English
Deutsch
